50 related articles for article (PubMed ID: 37182359)
1. Developing new PI3Kγ inhibitors by combining pharmacophore modeling, molecular dynamic simulation, molecular docking, fragment-based drug design, and virtual screening.
Zhu J; Sun D; Li X; Jia L; Cai Y; Chen Y; Jin J; Yu L
Comput Biol Chem; 2023 Jun; 104():107879. PubMed ID: 37182359
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel selective PI3Kγ inhibitors through combining machine learning-based virtual screening with multiple protein structures and bio-evaluation.
Zhu J; Li K; Xu L; Cai Y; Chen Y; Zhao X; Li H; Huang G; Jin J
J Adv Res; 2022 Feb; 36():1-13. PubMed ID: 35127160
[TBL] [Abstract][Full Text] [Related]
3. Optimization of virtual screening against phosphoinositide 3-kinase delta: Integration of common feature pharmacophore and multicomplex-based molecular docking.
Zhu J; Meng H; Li X; Jia L; Xu L; Cai Y; Chen Y; Jin J; Yu L
Comput Biol Chem; 2024 Apr; 109():108011. PubMed ID: 38198965
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel human nicotinamide N-methyltransferase inhibitors: a structure-based pharmacophore modeling and molecular dynamics approach.
Harikrishna AS; Venkitasamy K
J Biomol Struct Dyn; 2023; 41(24):14638-14650. PubMed ID: 36856058
[TBL] [Abstract][Full Text] [Related]
5. In silico analysis of marine natural product for protein arginine methyltransferase 5(PRMT5) inhibitors based on pharmacophore and molecular docking.
Luo L; Tan H; Liao Y
J Biomol Struct Dyn; 2023; 41(22):13180-13197. PubMed ID: 36856049
[TBL] [Abstract][Full Text] [Related]
6. Evolutionary chemical binding similarity approach integrated with 3D-QSAR method for effective virtual screening.
Durai P; Ko YJ; Pan CH; Park K
BMC Bioinformatics; 2020 Jul; 21(1):309. PubMed ID: 32664863
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation.
Wang Z; Sun L; Xu Y; Liang P; Xu K; Huang J
J Transl Med; 2023 Aug; 21(1):579. PubMed ID: 37641144
[TBL] [Abstract][Full Text] [Related]
8. Fragment-based discovery of new potential DNMT1 inhibitors integrating multiple pharmacophore modeling, 3D-QSAR, virtual screening, molecular docking, ADME, and molecular dynamics simulation approaches.
Lanka G; Banerjee S; Adhikari N; Ghosh B
Mol Divers; 2024 Apr; ():. PubMed ID: 38637479
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel SHP2 allosteric inhibitor using virtual screening, FMO calculation, and molecular dynamic simulation.
Yuan Z; Zhang M; Chang L; Chen X; Ruan S; Shi S; Zhang Y; Zhu L; Li H; Li S
J Mol Model; 2024 Apr; 30(5):131. PubMed ID: 38613643
[TBL] [Abstract][Full Text] [Related]
10. Pharmacophore-Based Virtual Screening of Novel Inhibitors and Docking Analysis for CYP51A from Penicillium italicum.
Yuan Y; Han R; Cao Q; Yu J; Mao J; Zhang T; Wang S; Niu Y; Liu D
Mar Drugs; 2017 Apr; 15(4):. PubMed ID: 28379163
[TBL] [Abstract][Full Text] [Related]
11. Computational workflow for discovering small molecular binders for shallow binding sites by integrating molecular dynamics simulation, pharmacophore modeling, and machine learning: STAT3 as case study.
Jaradat NJ; Hatmal M; Alqudah D; Taha MO
J Comput Aided Mol Des; 2023 Dec; 37(12):659-678. PubMed ID: 37597062
[TBL] [Abstract][Full Text] [Related]
12. Structure-based drug design and molecular dynamics studies of an allosteric modulator targeting the protein-protein interaction site of PDK1.
Kailasam Natesan V; Kuppannagounder Pitchaimuthu E
J Mol Model; 2024 Jan; 30(2):51. PubMed ID: 38277080
[TBL] [Abstract][Full Text] [Related]
13. Pharmacophore mapping approach to find anti-cancer phytochemicals with metformin-like activities against transforming growth factor (TGF)-beta receptor I kinase: An in silico study.
Reza R; Morshed N; Samdani MN; Reza MS
PLoS One; 2023; 18(11):e0288208. PubMed ID: 37943796
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a novel phosphoinositide 3-kinase gamma (PI3Kγ) inhibitor against hematologic malignancies and theoretical studies on its PI3Kγ-specific binding mechanisms.
Zhu J; Ke K; Xu L; Jin J
RSC Adv; 2019 Jun; 9(35):20207-20215. PubMed ID: 35546906
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Potential RAGE inhibitors using Receptor-Based Pharmacophore Modeling, High Throughput Virtual Screening and Docking Studies.
Singh H; Agrawal DK
J Biotechnol Biomed; 2023; 6(4):501-513. PubMed ID: 38050632
[TBL] [Abstract][Full Text] [Related]
16. Comparative Structure-Based Virtual Screening Utilizing Optimized AlphaFold Model Identifies Selective HDAC11 Inhibitor.
Baselious F; Hilscher S; Robaa D; Barinka C; Schutkowski M; Sippl W
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279359
[TBL] [Abstract][Full Text] [Related]
17. Development of PI3Kγ selective inhibitors: the strategies and application.
Gu DY; Zhang MM; Li J; Zhou YB; Sheng R
Acta Pharmacol Sin; 2024 Feb; 45(2):238-247. PubMed ID: 37803138
[TBL] [Abstract][Full Text] [Related]
18. A Review on Applications of Computational Methods in Drug Screening and Design.
Lin X; Li X; Lin X
Molecules; 2020 Mar; 25(6):. PubMed ID: 32197324
[TBL] [Abstract][Full Text] [Related]
19. Multiple target drug cocktail design for attacking the core network markers of four cancers using ligand-based and structure-based virtual screening methods.
Wong YH; Lin CL; Chen TS; Chen CA; Jiang PS; Lai YH; Chu L; Li CW; Chen JJ; Chen BS
BMC Med Genomics; 2015; 8 Suppl 4(Suppl 4):S4. PubMed ID: 26680552
[TBL] [Abstract][Full Text] [Related]
20. Molecular docking and structure-based drug design strategies.
Ferreira LG; Dos Santos RN; Oliva G; Andricopulo AD
Molecules; 2015 Jul; 20(7):13384-421. PubMed ID: 26205061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
